BPG致力于知识发现和传播
预出版
2020/12/21 3:00:02 | Browse: 176 | 下载: 234
Publication Name 世界华人消化杂志
手稿编号 37968
手稿来源省、自治区或特别行政区 浙江省
专业类型 消化内科学
手稿栏目类型 临床研究
文章标题 思连康联合艾司奥美拉唑钠治疗幽门螺杆菌相关性胃炎疗效及对NF-κB炎症信号通路的影响
手稿来源 自由来稿
所有作者列表 黄龙武, 李雷
基金项目及其编号
通讯作者 黄龙武, 本科, 主治医师, 313000, 浙江省湖州市吴兴区苕溪东路2088号, 湖州市第三人民医院内镜中心. . huanglongwu007@163.com
关键词 思连康; 优化二联疗法; 幽门螺杆菌; 相关性胃炎; 临床疗效; NF-κB炎症信号通路
核心内容提要 本文所研究的有别于现阶段临床常用在四联疗法基础上应用益生菌进行联合治疗, 而是提供一种新的方案, 即应用PPI和阿莫西林的二联疗法基础上, 加用益生菌治疗幽门螺杆菌(Helicobacter pylori, H. pylori)相关性胃炎, 且获得了显著疗效, 值得临床推荐使用.
引文著录 黄龙武, 李雷. 思连康联合艾司奥美拉唑钠治疗幽门螺杆菌相关性胃炎疗效及对NF-κB炎症信号通路的影响. 世界华人消化杂志 2021; 29(3): 131-137
Received
2020-10-26 00:09
Peer-Review Started
2020-10-26 03:03
To Make the First Decision
Return for Revision
2020-11-04 22:43
修回稿
2020-11-16 08:29
Second Decision
2020-12-11 07:27
期刊总编辑接受
公司总编辑接受
2020-12-21 03:00
预出版
2020-12-21 03:00
缴纳版面费
Edit the Manuscript by Language Editor
排版
2021-02-08 10:05
ISSN 1009-3079 (print) and 2219-2859 (online)
开放获取 This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权 © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址 http://www.wjgnet.com
Assistant Editor 王栋梅
Science Editor 张砚梁
评议人编号 03080171, 03123301, 03228365, 03735187, 02539740, and 03263166
Editorial Director
Journal Chief Editor
Company Chief Editor 马连生
Language Editor
Production Editor 张砚梁
Responsible Production Editor 张砚梁
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma